mAbs (Jan 2021)

One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeutics

  • Wei Chen,
  • Fan Yang,
  • Carole Wang,
  • Jatin Narula,
  • Edward Pascua,
  • Irene Ni,
  • Sheng Ding,
  • Xiaodi Deng,
  • Matthew Ling-Hon Chu,
  • Amber Pham,
  • Xiaoyue Jiang,
  • Kevin C. Lindquist,
  • Patrick J. Doonan,
  • Tom Van Blarcom,
  • Yik Andy Yeung,
  • Javier Chaparro-Riggers

DOI
https://doi.org/10.1080/19420862.2020.1871171
Journal volume & issue
Vol. 13, no. 1

Abstract

Read online

T-cell engaging biologics is a class of novel and promising immune-oncology compounds that leverage the immune system to eradicate cancer. Here, we compared and contrasted a bispecific diabody-Fc format, which displays a relatively short antigen-binding arm distance, with our bispecific IgG platform. By generating diverse panels of antigen-expressing cells where B cell maturation antigen is either tethered to the cell membrane or located to the juxtamembrane region and masked by elongated structural spacer units, we presented a systematic approach to investigate the role of antigen epitope location and molecular formats in immunological synapse formation and cytotoxicity. We demonstrated that diabody-Fc is more potent for antigen epitopes located in the membrane distal region, while bispecific IgG is more efficient for membrane-proximal epitopes. Additionally, we explored other parameters, including receptor density, antigen-binding affinity, and kinetics. Our results show that molecular format and antigen epitope location, which jointly determine the intermembrane distance between target cells and T cells, allow decoupling of cytotoxicity and cytokine release, while antigen-binding affinities appear to be positively correlated with both readouts. Our work offers new insight that could potentially lead to a wider therapeutic window for T-cell engaging biologics in general.

Keywords